This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of nasal cavity and middle ear
C3_NASAL_CAVITY_MIDDLE_EAR
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
166 |
4. Check minimum number of eventsNone |
166 |
5. Include endpointsNone |
166 |
6. Filter based on genotype QC (FinnGen only) |
156 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of nasal cavity and middle ear
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of nasal cavity and sinuses
- Malignant neoplasm of nasal cavity and middle ear, including Hilmo
- Malignant neoplasm of nasal cavity and sinuses, including Hilmo
- Malignant neoplasm of respiratory system and intrathoracic organs
- Solid cancers, helper endpoint
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 156 | 65 | 91 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.04 |
| Median age at first event (years) | 64.99 | 64.53 | 65.32 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 166
- Matched controls
- 1660
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
141.7
115
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
25.5
89.5
75
52
130
Kela drug reimbursment
Malignant tumour
+∞
63.7
57
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
167.2
63.1
63
6
XX3DW
NOMESCO Finland
Time consuming IT work
20.6
60.7
52
36
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
226.5
60.5
59
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
57.7
52
*
DHB10
NOMESCO Finland
Excision of lesion of internal nose
+∞
49.5
45
*
8070/3-C30.0
ICD-O-3
Squamous cell carcinoma, NOS, of nasal cavity
+∞
48.3
44
*
H02AB02
ATC
dexamethasone; systemic
133.7
46.7
48
5
WF002
NOMESCO Finland
Radical radiotherapy
269.9
42.0
41
*
A03FA01
ATC
metoclopramide; systemic, rectal
9.3
41.7
66
110
WZC00
NOMESCO Finland
Treatment plan or consultation
7.5
38.6
94
245
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
228.0
36.3
36
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
32.3
30
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
31.2
29
*
A04AA02
ATC
granisetron; systemic, transdermal
365.2
30.9
30
*
R04.0
ICD-10 Finland
Epistaxis
8.7
30.7
46
70
EP1AE
NOMESCO Finland
Neck ultrasound examination
13.9
30.0
30
26
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
+∞
27.9
26
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
49.0
27.0
32
8
A04AA01
ATC
ondansetron; systemic, rectal
31.2
26.6
35
14
8720/3-C30.0
ICD-O-3
Malignant melanoma, NOS, of nasal cavity
+∞
25.7
24
*
N02AA05
ATC
oxycodone; systemic
6.1
25.7
58
134
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
24.6
23
*
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
11.0
24.2
28
30
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
23.5
22
*
Z51.5
ICD-10 Finland
Palliative care
22.1
23.4
34
19
UDM02
NOMESCO Finland
Sinoscopy
34.7
22.8
29
10
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
132.6
22.2
23
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
251.8
22.2
22
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
21.3
20
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
238.7
21.1
21
*
DJB10
NOMESCO Finland
Excision of septum of nose
+∞
20.2
19
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
27.7
19.3
26
11
ZX090
NOMESCO Finland
Other technic of radiotherapy
79.5
19.2
21
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
19.1
18
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
20.8
19.0
28
16
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
213.1
18.9
19
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
22.7
18.9
27
14
UDQ12
NOMESCO Finland
Flexible laryngoscopy
7.1
18.5
31
52
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
59.7
18.4
21
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
17.6
65
218
D38.58
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other respiratory organ
+∞
17.0
16
*
WX402
NOMESCO Finland
General anaesthesia
4.4
15.9
50
147
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
15.9
15
*
DPC35
NOMESCO Finland
Extensive endoscopic excision of lesion or neoplasm extending to more than one paranasal sinus
+∞
15.9
15
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
15.9
15
*
L03AA02
ATC
filgrastim; parenteral
94.2
15.9
17
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
5.5
15.8
35
77
ZXE30
NOMESCO Finland
More than five and less than seven hours
14.4
15.5
26
21
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.8
15.3
26
44
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
88.1
14.8
16
*
9522/3-C30.0
ICD-O-3
Olfactory neuroblastoma of nasal cavity
+∞
14.8
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.8
14
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
16.5
14.6
23
16
DPA30
NOMESCO Finland
Sphenotomy
47.0
14.4
17
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.5
14.1
41
113
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
81.7
13.8
15
*
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
13.7
13
*
C72.2
ICD-10 Finland
Malignant neoplasm: Olfactory nerve
+∞
13.7
13
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
13.7
13
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.7
13
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
151.9
13.7
14
*
DHB40
NOMESCO Finland
Conchotomy
151.9
13.7
14
*
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
+∞
12.7
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.7
12
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
12.7
12
*
ZZR00
NOMESCO Finland
Flap of skin
+∞
12.7
12
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.2
12.4
86
416
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
23.5
12.3
17
8
A07AA02
ATC
nystatin; oral
5.8
12.1
24
47
EBA10
NOMESCO Finland
Operative extraction of tooth
4.7
11.7
30
74
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
+∞
11.6
11
*
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
+∞
11.6
11
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
+∞
11.6
11
*
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
+∞
11.6
11
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
11.6
11
*
JN4BD
NOMESCO Finland
Extensive body CT
6.2
11.5
21
38
SAA03
NOMESCO Finland
Extended examination of mouth
3.0
10.8
79
388
AA1BD
NOMESCO Finland
Extensive CT of head and brain
17.5
10.6
16
10
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
+∞
10.5
10
*
L01CB01
ATC
etoposide; systemic
+∞
10.5
10
*
EEB00
NOMESCO Finland
Partial excision of maxilla
+∞
10.5
10
*
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
+∞
10.5
10
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
10.5
10
*
JN4AD
NOMESCO Finland
Body CT examination
5.8
10.4
20
38
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
42.9
10.1
12
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.8
9.8
34
105
JDB10
NOMESCO Finland
Percutaneous gastrostomy
58.5
9.8
11
*
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
+∞
9.5
9
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
9.5
9
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
9.5
9
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
9.5
9
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
9.5
9
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
9.5
9
*
DHB00
NOMESCO Finland
Excision of lesion of external nose
+∞
9.5
9
*
DHB01
NOMESCO Finland
Partial excision of external nose
+∞
9.5
9
*
DLW99
NOMESCO Finland
Other plastic operations on nose
+∞
9.5
9
*
ZXC95
NOMESCO Finland
Use of surgical navigator
20.0
9.1
13
7
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
20.0
9.1
13
7
J33.0
ICD-10 Finland
Polyp of nasal cavity
11.7
9.0
16
15
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.9
8.9
21
48
WZC30
NOMESCO Finland
Teaching
3.7
8.9
31
96
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.3
8.6
18
37
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
8.4
8
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
8.4
8
*
AAE05
NOMESCO Finland
Nasoendoscopic closure of cerebrospinal fluid fistula
+∞
8.4
8
*
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
+∞
8.4
8
*
C31.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of accessory sinuses
+∞
8.4
8
*
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
10.9
8.2
15
15
ZXA05
NOMESCO Finland
Left side
2.7
8.2
58
273
ZXE40
NOMESCO Finland
More than seven and less than nine hours
23.4
8.1
11
5
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
23.4
8.1
11
5
R4190
NOMESCO Finland
Nutritional therapy
10.2
8.0
15
16
L03AA13
ATC
pegfilgrastim; parenteral
47.2
7.8
9
*
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
12.7
7.7
13
11
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
7.7
28
89
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
9.0
7.5
15
18
UDC00
NOMESCO Finland
Ear microscopy
3.7
7.5
25
75
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
7.3
7
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
7.3
7
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
7.3
7
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
7.3
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
7.3
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.3
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.3
7
*
8020/3-C30.0
ICD-O-3
Carcinoma, undifferentiated, NOS, of nasal cavity
+∞
7.3
7
*
ZX120
NOMESCO Finland
Intravenous
4.2
7.0
20
53
WW500
NOMESCO Finland
Blood transfusion
10.0
6.9
13
14
H65.2
ICD-10 Finland
Chronic serous otitis media
17.6
6.8
10
6
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
41.8
6.8
8
*
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
6.2
6.7
17
30
WX110
NOMESCO Finland
Infiltration anesthesia
2.5
6.6
116
805
SPF20
NOMESCO Finland
Temporary relining of dentures
72.5
6.5
7
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
72.5
6.5
7
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.6
6.4
46
215
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
6.3
43
195
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
6.3
26
89
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
18.9
6.3
9
5
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
18.9
6.3
9
5
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
27.8
6.3
8
*
8200/3-C30.0
ICD-O-3
Adenoid cystic carcinoma of nasal cavity
+∞
6.3
6
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
+∞
6.3
6
*
L01AX03
ATC
temozolomide; systemic
+∞
6.3
6
*
D36.7
ICD-10 Finland
Benign neoplasm: Other specified sites
+∞
6.3
6
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
6.3
6
*
8072/3-C30.0
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of nasal cavity
+∞
6.3
6
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
DKW40
NOMESCO Finland
Ligature of artery of internal nose
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
+∞
6.3
6
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.7
6.2
21
63
ZZA00
NOMESCO Finland
Split skin graft
10.6
6.1
11
11
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
6.0
38
166
EBA15
NOMESCO Finland
Extraction of multiple teeth
6.8
6.0
14
22
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
106
522
3.85
15.97
3.4
2.2
—
—
—
0
0
113
602
3.75
14.63
6.7
5.6
1.20
1.21
mmol/l
0.77
94
525
117
673
3.50
12.68
14.7
6.0
3.94
4.27
e9/l
0.88
104
587
12
10
12.82
7.20
1.1
1.1
—
—
—
0
0
53
259
2.54
6.75
2.1
1.9
—
—
—
0
0
35
148
2.73
5.89
5.7
6.5
0.80
1.35
mmol/l
0.26
26
123
10
9
11.72
5.88
1.2
1.3
—
—
—
0
0
22
76
3.18
5.27
1.3
1.5
—
—
—
0
0
13
24
5.78
5.03
1.2
1.5
—
—
—
0
0
8
7
11.92
4.83
2.1
1.6
13.34
11.71
ug/l
—
8
7
31
136
2.57
4.82
2.0
1.7
—
—
—
0
0
28
117
2.68
4.79
5.4
3.1
—
—
—
0
0
30
134
2.51
4.49
2.0
1.7
—
—
—
0
0
34
163
2.37
4.37
5.4
5.7
102.94
104.77
mmol/l
1.10
34
163
8
9
9.26
4.33
1.9
2.3
—
—
—
0
0
14
34
4.40
4.32
1.9
3.6
—
—
—
0
0
55
329
2.00
4.04
2.5
2.9
0.20
0.35
e6/l
0.76
39
246
66
424
1.92
3.93
2.8
3.0
—
—
—
0
0
35
184
2.14
3.59
2.1
1.7
—
—
—
0
0
106
1276
0.53
3.55
3.7
4.8
1.39
1.43
mmol/l
0.59
97
1169
22
95
2.52
3.52
4.3
1.9
66.18
66.84
ml/min/173m2
0.03
11
31
7
12
6.03
3.05
1.9
1.1
—
—
—
0
0
9
21
4.47
3.04
2.4
2.7
3.61
4.17
g/l
—
9
21
10
26
4.02
3.03
1.4
1.3
—
—
—
0
0
6
9
6.86
2.89
1.8
2.1
—
—
—
0
0
104
1234
0.58
2.79
3.5
4.3
1.37
1.31
mmol/l
0.43
93
1119
110
1284
0.58
2.73
3.9
4.8
4.61
4.55
mmol/l
0.25
102
1181
83
622
1.67
2.68
6.7
14.7
1.23
1.35
inr
0.43
29
181
5
7
7.32
2.56
2.4
1.0
—
—
—
0
0
9
26
3.60
2.52
1.9
1.7
—
—
—
0
0
98
775
1.65
2.51
4.0
4.3
391.86
384.80
e6/l
—
7
10
7
19
3.80
2.17
1.3
1.4
—
—
—
0
0
30
468
0.56
2.16
3.8
3.9
7.77
7.87
mg/mmol
0.00
19
306
115
1306
0.61
2.13
4.1
5.5
2.67
2.67
mmol/l
0.02
104
1200
7
21
3.43
1.99
2.9
2.1
216.29
178.62
%
—
7
21
6
16
3.85
1.95
7.7
3.2
68.33
56.75
%
—
6
16
140
1249
1.77
1.93
25.1
12.4
25.31
22.58
mg/l
0.56
127
958
7
22
3.27
1.90
1.1
1.5
—
—
—
0
0
12
240
0.46
1.85
1.2
1.3
9.44
1.98
u/ml
—
5
63
5
12
4.26
1.83
1.6
1.4
—
—
—
0
0
5
12
4.26
1.83
1.4
1.4
—
—
—
0
0
44
307
1.59
1.78
2.9
3.9
0.00
0.00
estimate
-0.00
16
93
6
18
3.42
1.76
1.3
1.3
—
—
—
0
0
49
357
1.53
1.63
4.2
2.3
320.80
10144.57
umol/l
2.29
44
306
5
14
3.65
1.62
1.0
1.4
—
—
—
0
0
5
15
3.40
1.53
1.6
1.3
—
—
—
0
0
5
16
3.19
1.45
1.0
1.0
—
—
—
0
0
19
115
1.74
1.31
2.8
3.7
107.21
180.60
ng/l
0.99
19
102
5
18
2.83
1.29
2.8
1.3
—
—
—
0
0
5
18
2.83
1.29
2.8
1.3
—
—
—
0
0
8
39
2.10
1.17
6.5
1.3
70.91
37.42
mg/l
—
8
34
12
65
1.91
1.17
1.8
1.6
—
—
—
0
0
7
30
2.39
1.14
1.6
1.2
—
—
—
0
0
14
81
1.80
1.13
6.7
7.8
0.76
0.76
%
0.02
14
81
117
1277
0.72
1.11
4.5
4.9
6.06
6.07
mmol/l
0.02
106
1154
20
130
1.61
1.09
2.5
3.2
2.99
1.90
mmol/l
1.07
20
99
20
131
1.60
1.06
2.5
3.2
6.06
5.68
kpa
1.08
20
126
130
1192
1.42
1.05
23.3
11.6
83.08
77.80
ml/min/173m2
2.33
113
960
144
1349
1.51
0.99
28.8
14.6
74.50
80.72
umol/l
2.98
144
1349
9
51
1.81
0.96
5.9
1.2
9.10
10.01
g/l
—
9
42
125
1159
1.32
0.78
4.8
4.6
2.12
1.94
mu/l
0.59
118
1038
13
83
1.61
0.77
6.8
7.8
1.56
1.56
%
0.00
13
83
6
34
1.79
0.77
1.0
1.2
—
—
—
0
0
69
598
1.26
0.74
3.0
3.6
0.00
0.00
estimate
-0.00
18
106
9
56
1.64
0.74
5.9
1.3
2.50
2.93
g/l
—
9
47
7
39
1.83
0.73
7.3
1.3
24.07
54.94
mg/l
—
7
34
5
25
2.03
0.73
1.2
1.3
52.80
57.80
pmol/l
—
5
25
34
273
1.31
0.65
1.6
1.6
2.55
1.04
mg/l
1.17
29
208
56
481
1.25
0.63
3.2
3.7
—
—
—
0
0
48
561
0.80
0.63
2.0
1.9
86.33
94.71
pmol/l
0.78
26
277
5
88
0.55
0.58
1.6
1.8
—
—
—
0
0
9
59
1.56
0.56
5.9
1.3
—
—
—
0
0
9
59
1.56
0.56
5.9
1.3
6.26
7.69
g/l
—
9
50
9
59
1.56
0.56
5.9
1.3
3.59
3.76
g/l
—
9
50
21
162
1.34
0.53
1.6
2.4
2.34
2.26
g/l
0.23
21
148
146
1404
1.33
0.53
33.0
18.4
37.21
40.45
%
5.17
140
1299
146
1405
1.32
0.51
32.9
18.4
4.20
4.53
e12/l
9.60
141
1357
146
1406
1.32
0.50
33.0
18.5
125.99
137.24
g/l
13.17
146
1379
7
47
1.51
0.48
7.1
1.2
40.69
37.57
g/l
—
7
38
116
1223
0.83
0.47
5.2
6.5
40.50
40.60
mmol/mol
0.04
106
1130
67
602
1.19
0.47
4.1
5.1
0.00
0.00
estimate
-0.00
17
99
7
48
1.48
0.47
7.7
1.1
0.49
0.26
g/l
—
7
41
68
612
1.19
0.47
3.1
3.7
0.00
0.00
estimate
-0.00
16
92
22
176
1.29
0.44
1.8
2.4
17.37
13.49
umol/l
0.36
22
159
5
31
1.63
0.43
1.2
1.1
—
—
—
0
0
5
32
1.58
0.42
1.8
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
13
97
1.37
0.41
4.9
1.9
63.85
66.28
g/l
0.60
13
85
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
9
67
1.36
0.39
2.3
1.6
—
—
—
0
0
54
487
1.16
0.36
2.0
2.4
72.49
76.64
nmol/l
0.59
49
427
10
75
1.35
0.31
1.4
1.7
—
—
—
0
0
11
86
1.30
0.27
1.6
1.9
—
—
—
0
0
20
170
1.20
0.26
11.8
6.7
—
—
—
0
0
5
38
1.33
0.23
2.6
1.4
—
—
—
0
0
5
42
1.20
0.21
2.8
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
22
193
1.16
0.21
2.8
2.8
0.00
2.12
e6/l
—
10
101
8
68
1.19
0.17
1.9
2.2
0.79
1.39
%
—
8
68
70
675
1.06
0.11
2.7
2.8
—
—
—
0
0
15
134
1.13
0.11
1.4
1.3
—
—
—
0
0
15
166
0.89
0.10
1.1
1.4
—
—
—
0
0
58
558
1.06
0.10
3.7
3.8
1045.08
47.22
ng/l
0.49
44
405
12
106
1.14
0.10
2.3
2.5
4.58
4.61
kpa
0.01
12
99
22
204
1.09
0.09
2.7
2.6
0.41
1.01
e6/l
—
10
112
45
441
1.03
0.02
4.7
3.5
23.71
24.46
%
0.10
27
197
26
268
0.96
0.02
1.4
1.7
1151.99
1209.33
nmol/l
0.13
21
196
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
56.86
—
0
9
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
143.79
—
0
9
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
9.29
—
0
7
0
9
0.00
0.00
0.0
2.8
—
17.94
—
0
9
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.0
—
635.75
—
0
8
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
55
0.91
-0.00
1.0
2.6
29.60
41.84
u/l
—
5
50
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
67.66
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_NASAL_CAVITY_MIDDLE_EAR – Malignant neoplasm of nasal cavity and middle ear
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).